A new test gauging levels of key proteins in the blood was far more accurate than doctor assessments in spotting Alzheimer’s disease in people with early-stage illness. The test, called APS2 (the amyloid probability score 2), was 91% accurate in diagnosing Alzheimer’s in people with mild cognitive decline or early dementia, compared to the 61% success rate of primary care doctors who examined the same patients. The test isn’t yet approved for routine use. But Dr Teresa D’Amato, director of geriatric emergency medicine at Northwell Health in Forest Hills, NY, called the new data “very exciting.” “This blood test would Read More
No comments:
Post a Comment